An FDA 483 is one of the most stressful documents a dietary supplement manufacturer can receive. But how you respond to it will largely determine what happens next — whether you face follow-up action, a Warning Letter, or come through the inspection with your operations intact.
This guide walks through exactly how to handle a 483 response from the moment the investigator hands it to you through to submission.
What Is an FDA Form 483?
FDA Form 483 — officially called "Inspectional Observations" — is a document issued by an FDA investigator at the conclusion of a facility inspection when the investigator has observed conditions or practices that may constitute violations of applicable laws and regulations.
A 483 is not a Warning Letter, and it is not a final determination of violations. It is a list of observations that the investigator documented during the inspection. You have the opportunity to respond before the FDA determines its next action.
Time is critical: While there is no legally mandated deadline for a 483 response, the FDA strongly expects a written response within 15 business days of receiving the form. Responding promptly demonstrates good faith and directly influences whether the agency escalates to a Warning Letter or Consent Decree.
Step-by-Step: How to Respond
Read Every Observation Carefully — and Resist the Urge to Minimize
Read each observation in full before doing anything else. Understand exactly what the investigator documented. Avoid the instinct to dismiss or minimize observations — even if you believe they are factually incorrect, a dismissive response will work against you. The FDA has seen every variation of "we were already aware of this" and it does not reduce their concern.
Assign Ownership for Each Observation
Assign a specific, accountable person to each observation. This person is responsible for the root cause analysis, corrective action, and gathering evidence for that item. Do not let 483 responses be written by one person working alone — the individuals closest to each process will identify root causes more accurately.
Conduct a True Root Cause Analysis
This is the most important — and most commonly botched — step. The FDA is not satisfied with symptom-level responses. They want to know why the observation occurred, not just that it occurred. Use structured tools (5 Whys, Fishbone/Ishikawa diagrams) to get to the actual root cause. If your SOP was missing a step, why was it missing? If training was inadequate, why was the training program not designed to catch this gap?
Develop a CAPA Plan for Each Observation
A Corrective and Preventive Action (CAPA) plan must address both the immediate correction (stopping the problem now) and the preventive action (ensuring it cannot recur). For each observation, your CAPA must include: what was done immediately, what systemic changes will be made, who is responsible, and target completion dates. Dates must be realistic — the FDA will follow up and check.
Gather and Attach Supporting Evidence
Wherever possible, provide documentary evidence that corrective actions have already been completed or are underway. Revised SOPs, updated training records, equipment calibration certificates, new batch record forms — anything you can attach as an exhibit strengthens your response substantially. A response that says "we will do X" is weaker than one that says "we have done X, see Exhibit A."
Write a Professional, Observation-by-Observation Response
Structure your response letter to address each observation individually, numbered to match the 483. For each observation: acknowledge it, state your root cause finding, describe your immediate correction, describe your systemic CAPA, and provide your timeline and responsible parties. Use professional, non-defensive language throughout. The tone should convey that you take the observations seriously and have mobilized your organization to address them.
What to Avoid in Your 483 Response
- Disagreeing with observations without strong factual basis — if you dispute a finding, you need documented evidence, not opinion
- Vague commitments with no dates — "we will update our procedures" with no timeline signals that you haven't actually prioritized the issue
- Blaming personnel without systemic correction — the FDA expects system-level fixes, not just retraining of individuals
- Promising actions you cannot complete — if you commit to a date and miss it, your credibility with the district office deteriorates
- Copying boilerplate language — FDA investigators read hundreds of responses; generic language signals lack of genuine engagement
- Treating the response as the end — your 483 response opens a file that the FDA tracks; your next inspection will verify whether your commitments were honored
What Happens After You Submit
The FDA district office reviews your response and makes a determination about whether to escalate. If your response is substantive, demonstrates genuine corrective action, and provides evidence of implementation, the district office may close the matter. If your response is inadequate — or if you don't respond at all — escalation to a Warning Letter becomes significantly more likely.
A Warning Letter is public record, appears on the FDA website, and can trigger immediate problems with retailers, distributors, and customers. The 15-business-day response window is not a suggestion.
After submission: Keep copies of everything submitted. Document the dates of all corrective actions as they are completed. If the FDA returns for a follow-up inspection, they will check whether your commitments were honored — and they will check thoroughly.
When to Bring in Outside Help
If the 483 observations are numerous, technically complex, or touch on systemic quality system failures, attempting to write the response internally without regulatory expertise is a significant risk. The cost of a well-written response is a fraction of the cost of a Warning Letter — and a fraction of the cost of the disruption a Warning Letter causes with your retail partners.
Ready to Get GMP Certified?
Book a free 30-minute compliance consultation with a GummyGMP expert. We'll map out exactly what your facility needs to reach certification.
Book Your Free Call →